Skip NavigationSkip to Content

Design and initial characterization of a circular permuted variant of the potent HIV-inactivating protein cyanovirin-N

  1. Author:
    Barrientos, L. G.
    Louis, J. M.
    Hung, J.
    Smith, T. H.
    O'Keefe, B. R.
    Gardella, R. S.
    Mori, T.
    Boyd, M. R.
    Gronenborn, A. M.
  2. Author Address

    NIDDKD, Chem Phys Lab, NIH, Bldg 5, Room 130, Bethesda, MD 20892 USA. NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA. NCI, Lab Drug Discovery Res & Dev, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA. NCI, SAIC, Frederick, MD 21701 USA. Gronenborn AM NIDDKD, Chem Phys Lab, NIH, Bldg 5, Room 130, Bethesda, MD 20892 USA.
    1. Year: 2002
  1. Journal: Proteins-Structure Function and Genetics
    1. 46
    2. 2
    3. Pages: 153-160
  2. Type of Article: Article
  1. Abstract:

    A circular permuted variant of the potent human immunodeficiency virus (HIV)-inactivating protein cyanovirin-N (CV-N) was constructed. New N- and C-termini were introduced into an exposed helical loop, and the original termini were linked using residues of the original loop. Since the three- dimensional structure of wild-type cyanovirin-N is a pseudodimer, the mutant essentially exhibits a swap between the two pseudo-symmetrically related halves. The expressed protein, which accumulates in the insoluble fraction, was purified, and conditions for in vitro refolding were established. During refolding, a transient dimeric species is also formed that converts to a monomer. Similar to the wild-type CV-N, the monomeric circular permuted protein exhibits reversible thermal unfolding and urea denaturation. The mutant is moderately less stable than the wild-type protein, but it displays significantly reduced anti-HIV activity. Using nuclear magnetic resonance spectroscopy, we demonstrate that this circular permuted monomeric molecule adopts the same fold as the wild- type protein. Characterization of these two architecturally very similar molecules allows us to embark, for the first time, on a structure guided focused mutational study, aimed at delineating crucial features for the extraordinary difference in the activity of these molecules. Proteins 2002;46:153-160. 2001 Wiley-Liss, Inc.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel